Literature DB >> 24406176

[Early experience of resection of meningiomas in anterior skull base with intra-extracranial extension via a pure endoscopic endonasal approach].

Zhen-lin Wang1, Qiu-hang Zhang2, Hong-chuan Guo, Feng Kong, Ge Chen, Yu-hai Bao, Feng Ling.   

Abstract

OBJECTIVE: The early experience of treating anterior skull base meningiomas with intra-extracranial extension via pure endoscopic endonasal approach (EEA) was presented, the safety, feasibility and preliminary treatment outcomes were investigated.
METHODS: Eight patients with intra-extradural meningiomas who were admitted from October 2006 to October 2010 were operated on via EEA in one stage in Xuanwu hospital. In this study, the operative technique was described, the degree of resection, complications and the early clinical outcomes were discussed.
RESULTS: The complete resection of meningiomas with intra-extracranial extension was achieved in all patients using EEA in one stage. Preoperative visual symptoms were improved or resolved in all cases who presented with preoperative visual complaints. No patient in our series experienced a new neurological deficit after surgery or recurrence and death related meningiomas in the follow-up period (33-75 months). One patient experienced postoperative cerebrospinal fluid leak, delayed meningitis and secondary hydrocephalus which responded to therapy. After treatment, the patient was cure.
CONCLUSION: Our limited experience indicates that EEA is feasible and safe for the complete resection of anterior skull base meningiomas with intra- and extracranial extension in one stage in selected cases.

Entities:  

Mesh:

Year:  2013        PMID: 24406176

Source DB:  PubMed          Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1673-0860


  1 in total

1.  Pedicled frontal periosteal rescue flap via eyebrow incision for skull base reconstruction (SevEN-002).

Authors:  Chang Ki Jang; Soo Jeong Park; Eui Hyun Kim; Jin Mo Cho; Ju Hyung Moon; Kyoung Su Sung; Je Beom Hong; Jaejoon Joon Lim; Minkyun Na; Chang-Ki Hong; Tae Hoon Roh; Jiwoong Oh
Journal:  BMC Surg       Date:  2022-04-29       Impact factor: 2.030

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.